Research Projects & Grants

For Profit Organization

  • Ultrasound-based renal sympathetic denervation as adjunctive upstream therapy during atrial fibrillation ablation: a pilot study (ULTRA-HFIB), Role: PI, ReCor Medical, Inc., (02/2026 - 02/2027) Status: Approved
  • EnSite precision observational study - SJM-CIP-10159, Role: PI, St. Jude Medical Inc., (07/2019 - 07/2020) Status: Completed
  • HEAL-IST IDE: Hybrid epicardial and endocardial sinus-node sparing ablation therapy for inappropriate sinus tachycardia, Role: Investigator, AtriCure Inc., (06/2025 - 06/2026) Status: Approved
  • WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device with Alternative Post-Implant Monotherapy (SIMPLAAFY), Role: PI, Boston Scientific Corp., (02/2026 - 02/2027) Status: Approved
  • ULTRASOUND-BASED RENAL SYMPATHETIC DENERVATION AS ADJUNCTIVE UPSTREAM THERAPY DURING ATRIAL FIBRILLATION – REDO ABLATION PROCEDURES: A Pilot Study, Role: PI, ReCor Medical, Inc., (05/2026 - 05/2027) Status: Approved
  • An Evaluation of the Safety and Effectiveness of the Conformal CLAAS System for Left Atrial Appendage Occlusion, Role: PI, Conformal Medical, Inc., (05/2026 - 05/2027) Status: Approved
  • Inappropriate Sinus Tachycardia (IST) Registry. A Multicenter Observational Data Registry for Outcomes of Inappropriate SinusTachycardia and Postural Orthostatic Tachycardia Syndrome Treatment, Role: Investigator, AtriCure Inc., (12/2024) Status: Approved
  • Watchmen FLX™ Left Atrial Appendage Closure Device with Delivery System, or any next generation models approved following study commencement. Placebo, Role: PI, Hamilton Health Sciences Corporation, Status: Approved

Internal

  • ExternalizeD implantablE CardiAc Electronic DevicEs - DECADE Study, Role: Investigator, LLU Dept. of Medicine, (08/2022) Status: Approved